Ledger.Open graph →
SEC Form D · filed August 23, 2024

TENAX THERAPEUTICS, INC

Offering
$175.0M
Sold
$99.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHAPEL HILL, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Declan R. Doogan · Chapel Hill, NCDirectorJune M. Almenoff · Chapel Hill, NCDirectorRobyn M. Hunter · Chapel Hill, NCDirectorMichael R. Davidson · Chapel Hill, NCDirectorStuart M. Rich · Chapel Hill, NCExec · DirectorLawrence R. Hoffman · Chapel Hill, NCExecChristopher T. Giordano · Morrisville, NCExec · DirectorGerald T. Proehl · San Diego, CADirectorMichael R. Davidson · Chapel Hill, NCDirectorStuart M. Rich · Chapel Hill, NCExec · DirectorLawrence R. Hoffman · Chapel Hill, NCExecChristopher T. Giordano · Morrisville, NCExec · DirectorDeclan R. Doogan · Chapel Hill, NCDirectorJune M. Almenoff · Chapel Hill, NCDirectorRobyn M. Hunter · Chapel Hill, NCDirectorGerald T. Proehl · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗